We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a ...

Moderna CFO Jamey Mock told Barron’s it would still be possible, despite the cuts. Mock said that while the company has cut back significantly on its capacity to put vaccine doses in vials, it ...

RNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman ...

Takeda Pharmaceutical Co., which imports and sells Moderna vaccines, is urging personnel involved in vaccinations to check each vial carefully, regardless of its lot number. Even if a vial is not ...

"Producing these vials is something that companies ... After that, it needs to be kept at colder temperatures. Moderna is also seeking FDA approval for its vaccine that has proven to be 94% ...

The Okinawa prefectural government had reported the day before that some of its Moderna vaccines may have been contaminated. Small, black foreign substances were detected in a vial that was ...

Leftover drops in vials of Moderna’s COVID-19 vaccine allowed a group of researchers from Stanford University to determine the sequence of the mRNA for SARS-CoV-2’s spike protein that is used in the ...

While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...

Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...

COPENHAGEN, DENMARK -- Finland has joined other Nordic countries in suspending or discouraging the use of Moderna's COVID-19 vaccine in certain age groups because of an increased risk of heart ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats ...